Asthma Clinical Trial
Official title:
Effect of a School Based Hand Sanitizer Program on Asthma
Asthma is a common, serious illness among children in the United States. Improving hand cleanliness and hygiene may prevent the spread of viruses that can cause asthma exacerbations. This study will evaluate the effectiveness of a school-based hand sanitizer program at reducing the frequency of exacerbations in children with asthma.
In the United States, almost 9 million children have been diagnosed with asthma. It is a
leading cause of hospitalizations and school absenteeism among children. Asthma symptoms are
often seasonal, with the greatest number of exacerbations occurring in autumn and the fewest
in mid-summer. Elementary school children are the most vulnerable to these seasonal changes,
and many children experience an increase in exacerbations at the beginning of the school
year. Recent research suggests that this seasonal peak in exacerbations is primarily caused
by viral respiratory tract infections that are spread among children in school. Regular
handwashing has been widely recognized as the most effective way to stop the spread of
viruses and infectious illnesses. However, effective handwashing methods among school-age
children can be inconsistent. Time constraints, a frequent lack of soap and towels,
inconveniently located sinks, and water-saving faucets are all barriers to thorough
handwashing. Improving hand hygiene through the use of antimicrobial rinse-free hand
sanitizers in school classrooms may be a simple and effective way to reduce the risk of
transmitting viruses that can cause asthma exacerbations. The purpose of this study is to
evaluate the effectiveness of a school-based hand sanitizer program at decreasing
exacerbations in children with asthma.
This study will enroll children with asthma who are attending one of the 32 participating
schools. Each school will be randomly assigned to either use their usual hand hygiene
practices in Year 1, followed by a two-step hand hygiene program including hand washing plus
hand sanitizer in Year 2, or vice versa. Each participant will log in to an Internet-based
data collection system on a daily basis to document their asthma symptoms and peak flow meter
readings. Teachers will also log in daily to verify participants' data and to document
participants' absences and the reason for the absence. Quick relief medication use will be
recorded and measured through the use of a Doser device on participants' inhalers.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04624425 -
Additional Effects of Segmental Breathing In Asthma
|
N/A | |
| Terminated |
NCT04410523 -
Study of Efficacy and Safety of CSJ117 in Patients With Severe Uncontrolled Asthma
|
Phase 2 | |
| Active, not recruiting |
NCT03927820 -
A Pharmacist-Led Intervention to Increase Inhaler Access and Reduce Hospital Readmissions (PILLAR)
|
N/A | |
| Completed |
NCT04617015 -
Defining and Treating Depression-related Asthma
|
Early Phase 1 | |
| Recruiting |
NCT03694158 -
Investigating Dupilumab's Effect in Asthma by Genotype
|
Phase 4 | |
| Terminated |
NCT04946318 -
Study of Safety of CSJ117 in Participants With Moderate to Severe Uncontrolled Asthma
|
Phase 2 | |
| Completed |
NCT04450108 -
Vivatmo Pro™ for Fractional Exhaled Nitric Oxide (FeNO) Monitoring in U.S. Asthmatic Patients
|
N/A | |
| Completed |
NCT03086460 -
A Dose Ranging Study With CHF 1531 in Subjects With Asthma (FLASH)
|
Phase 2 | |
| Completed |
NCT01160224 -
Oral GW766944 (Oral CCR3 Antagonist)
|
Phase 2 | |
| Completed |
NCT03186209 -
Efficacy and Safety Study of Benralizumab in Patients With Uncontrolled Asthma on Medium to High Dose Inhaled Corticosteroid Plus LABA (MIRACLE)
|
Phase 3 | |
| Completed |
NCT02502734 -
Effect of Inhaled Fluticasone Furoate on Short-term Growth in Paediatric Subjects With Asthma
|
Phase 3 | |
| Completed |
NCT01715844 -
L-Citrulline Supplementation Pilot Study for Overweight Late Onset Asthmatics
|
Phase 1 | |
| Terminated |
NCT04993443 -
First-In-Human Study to Evaluate the Safety, Tolerability, Immunogenicity, and Pharmacokinetics of LQ036
|
Phase 1 | |
| Completed |
NCT02787863 -
Clinical and Immunological Efficiency of Bacterial Vaccines at Adult Patients With Bronchopulmonary Pathology
|
Phase 4 | |
| Recruiting |
NCT06033833 -
Long-term Safety and Efficacy Evaluation of Subcutaneous Amlitelimab in Adult Participants With Moderate-to-severe Asthma Who Completed Treatment Period of Previous Amlitelimab Asthma Clinical Study
|
Phase 2 | |
| Completed |
NCT03257995 -
Pharmacodynamics, Safety, Tolerability, and Pharmacokinetics of Two Orally Inhaled Indacaterol Salts in Adult Subjects With Asthma.
|
Phase 2 | |
| Completed |
NCT02212483 -
Clinical Effectiveness and Economical Impact of Medical Indoor Environment Counselors Visiting Homes of Asthma Patients
|
N/A | |
| Recruiting |
NCT04872309 -
MUlti-nuclear MR Imaging Investigation of Respiratory Disease-associated CHanges in Lung Physiology
|
||
| Withdrawn |
NCT01468805 -
Childhood Asthma Reduction Study
|
N/A | |
| Recruiting |
NCT05145894 -
Differentiation of Asthma/COPD Exacerbation and Stable State Using Automated Lung Sound Analysis With LungPass Device
|